NCT03657225

Brief Summary

Our intention is to perform a randomized controlled trial to compare the efficacy and safety of mini cardiopulmonary bypass system to a modified conventional bypass circuit in 80 Asian patients undergoing elective CABG. Our intend is to confirm the efficacy of mini-bypass in reducing haemodilution and reducing blood transfusions, and investigate if this is associated with reduced inflammation and better cardiovascular, neurological, renal, respiratory and infection outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 1, 2014

Completed
4 years until next milestone

First Posted

Study publicly available on registry

September 5, 2018

Completed
Last Updated

September 5, 2018

Status Verified

August 1, 2018

Enrollment Period

4.7 years

First QC Date

September 1, 2014

Last Update Submit

August 30, 2018

Conditions

Keywords

miniaturizedcardiopulmonary bypass

Outcome Measures

Primary Outcomes (1)

  • Acute kidney injury

    Meeting AKIN 1 criteria

    48 hours after surgery

Secondary Outcomes (2)

  • Neurocognitive decline

    3 months post surgery

  • Inflammation

    72 hours post surgery

Other Outcomes (1)

  • Atrial fibrillation

    7 days post surgery

Study Arms (2)

Mini CPB (ECCO, Sorin, Italy)

ACTIVE COMPARATOR

Utilization of the mini CPB circuit (Extra Corporeal Circuit Optimized; Phisio, Sorin Group, Italy)

Device: Utilization of the mini CPB circuit

Conventional

PLACEBO COMPARATOR

Use of conventional CPB circuit

Drug: Utilization of the conventional circuit

Interventions

Comparison of the mini CPB circuit to conventional circuit

Mini CPB (ECCO, Sorin, Italy)

Comparison of the mini CPB circuit to conventional circuit

Conventional

Eligibility Criteria

Age21 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • first time on pump CABG revascularization

You may not qualify if:

  • poor left ventricular ejection faction (\< 30%)
  • immunologic disease or malignancies
  • acute inflammatory disease
  • coagulopathy
  • steroid treatment
  • preoperative renal failure (currently receiving dialysis)
  • significant carotid disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National University Health System

Singapore, 119074, Singapore

Location

Related Publications (1)

  • Ti LK, Goh BL, Wong PS, Ong P, Goh SG, Lee CN. Comparison of mini-cardiopulmonary bypass system with air-purge device to conventional bypass system. Ann Thorac Surg. 2008 Mar;85(3):994-1000. doi: 10.1016/j.athoracsur.2007.09.001.

    PMID: 18291186BACKGROUND

MeSH Terms

Conditions

Acute Kidney InjuryTrauma, Nervous System

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesNervous System DiseasesWounds and Injuries

Study Officials

  • Lian K Ti, MBBS, MMed

    National University Health System, Singapore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2014

First Posted

September 5, 2018

Study Start

November 1, 2008

Primary Completion

July 1, 2013

Study Completion

July 1, 2014

Last Updated

September 5, 2018

Record last verified: 2018-08

Locations